Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04607980
What this trial is testing

Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 563
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Study completedNCT02326272
What this trial is testing

Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 227
Testing effectiveness (Phase 2)Study completedNCT02387853
What this trial is testing

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 117
Large-scale testing (Phase 3)Ended earlyNCT01708603
What this trial is testing

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Bausch Health Americas, Inc. 1,831
Large-scale testing (Phase 3)Study completedNCT02326298
What this trial is testing

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 234
Testing effectiveness (Phase 2)Study completedNCT00773734
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Who this might be right for
PsoriasisPlaque-type Psoriasis
Amgen 352
Testing effectiveness (Phase 2)Study completedNCT00601107
What this trial is testing

Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Genzyme, a Sanofi Company 111
Not applicableStudy completedNCT03167515
What this trial is testing

Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ferndale Laboratories, Inc. 95
Early research (Phase 1)Study completedNCT05504317
What this trial is testing

AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Akeso 48
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Large-scale testing (Phase 3)Active Not RecruitingNCT05172726
What this trial is testing

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Organon and Co 58
Large-scale testing (Phase 3)Study completedNCT03536884
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 743
Post-approval studies (Phase 4)UnknownNCT01228409
What this trial is testing

Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

Who this might be right for
Psoriasis
Frankel, Amylynne, M.D. 20
Post-approval studies (Phase 4)Ended earlyNCT00697593
What this trial is testing

ChangE From Any Systemic psoriasiS therapY to Raptiva

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 70
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Early research (Phase 1)Study completedNCT03210961
What this trial is testing

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 109
Large-scale testing (Phase 3)Study completedNCT02489227
What this trial is testing

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 545
Large-scale testing (Phase 3)Study completedNCT04036435
What this trial is testing

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 1,466
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation